Iceland· IS-EU/1/96/016/005-007
Norvir
A ritonavir product containing ritonavirum inn, registered in Iceland by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Ritonavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Ritonavir · ATC J05AE03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ritonavir costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ritonavir · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- FR France$4.15
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ritonavirum INN
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Iceland (IS)
- ATC code
- J05AE03
- ATC class
- Ritonavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean08873730 stk x1 glasISK 10379
- ean98874330 stk x1 pakkiISK 15523
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
515 interactions on record for ritonavir.
Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ritonavir · interactions on record
515 records
- 149 severe
- 238 moderate
- 19 minor
- 66 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
43 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ritonavir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNORVIRAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandNorvirParanova Oy
- United StatesNorvirAbbVie Inc.
- BelgiumKaletra 100 mg - 25 mgAbbVie Deutschland
- NetherlandsNorvir 100 mg, filmomhulde tabletAbbVie Deutschland GmbH & Co. KG
- PolandNorvirAbbVie Deutschland GmbH & Co. KG
- FranceNORVIR 100 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- SwedenNorvir 100 mg Filmdragerad tablettAbbVie Deutschland GmbH & Co KG
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Ritonavir Accord
- Belgium · Ritonavir Accord
- Cyprus · Ritonavir Accord
- Germany · Ritonavir Accord, Ritonavir Hexal
- Denmark · Ritonavir Accord
- Estonia · Ritonavir Auxilia
- Spain · Ritonavir Accord
- Finland · Ritonavir Accord
- France · Ritonavir Arrow
- United Kingdom (Northern Ireland) · Norvir, Ritonavir Accord Healthcare
- Hungary · Ritonavir Accord
- Italy · Ritonavir Sandoz
- Liechtenstein · Norvir, Ritonavir Viatris
- Netherlands · Ritonavir Accord, Ritonavir Sandoz
- Norway · Norvir, Ritonavir Viatris
- Poland · Ritonavir Accord, Ritonavir Aurovitas
- Portugal · Ritonavir Farmoz, Ritonavir Generis
- Sweden · Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2de9b6d-d49b-488b-ac47-5bccc4e93623 GET /v1/drugs/d2de9b6d-d49b-488b-ac47-5bccc4e93623?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "J05AE03",
"marketed": false,
"strength": "100 mg",
"ma_number": "EU/1/96/016/005-007",
"substance": "Ritonavirum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "40221"
}See everything about ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.